Takeda Pharmaceutical (TAK) Other Non-Current Assets: 2018-2025

  • Takeda Pharmaceutical's Other Non-Current Assets rose 33.30% to $460.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $460.7 million, marking a year-over-year increase of 33.30%. This contributed to the annual value of $461.4 million for FY2025, which is 29.92% up from last year.
  • Per Takeda Pharmaceutical's latest filing, its Other Non-Current Assets stood at $460.7 million for Q1 2025, which was up 33.30% from $345.6 million recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Other Non-Current Assets high stood at $948.0 million for Q1 2021, and its period low was $345.6 million during Q1 2024.
  • Its 3-year average for Other Non-Current Assets is $428.3 million, with a median of $460.7 million in 2025.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 32.65% in 2023, then spiked by 33.30% in 2025.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Other Non-Current Assets stood at $948.0 million in 2021, then fell by 25.01% to $710.9 million in 2022, then tumbled by 32.65% to $478.7 million in 2023, then decreased by 27.81% to $345.6 million in 2024, then soared by 33.30% to $460.7 million in 2025.
  • Its last three reported values are $460.7 million in Q1 2025, $345.6 million for Q1 2024, and $478.7 million during Q1 2023.